Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × X-Rays × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 24 Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 15 Breast Neoplasms 15 Sarcoma 12 Multiple Myeloma 12 Glioma 10 Lymphoma, Non-Hodgkin 9 Wilms Tumor 8 Osteosarcoma 8 Neuroblastoma 8 Leukemia, Myeloid, Acute 8 Rhabdoid Tumor 7 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Hepatoblastoma 7 Colorectal Neoplasms 7 Carcinoma, Hepatocellular 7 Rhabdomyosarcoma 6 Rectal Neoplasms 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Myelodysplastic Syndromes 6 Mouth Neoplasms 6 Medulloblastoma 6 Histiocytosis, Langerhans-Cell 6 Ependymoma 6 Sarcoma, Ewing 5 Pancreatic Neoplasms 5 Neoplasms 5 Melanoma 5

Interventions

Trastuzumab 6 Carboplatin 6 Docetaxel 5 Paclitaxel 4 Oxaliplatin 4 Fluorouracil 4 Cytarabine 4 Cyclophosphamide 4 Azacitidine 4 pertuzumab 3 pembrolizumab 3 Radiotherapy 3 Observation 3 Epirubicin 3 Endoscopy 3 Cisplatin 3 Chemoradiotherapy 3 Capecitabine 3 venetoclax 2 sargramostim 2 olaparib 2 durvalumab 2 cc-486 2 Surgical Procedures, Operative 2 Standard of Care 2 Pemetrexed 2 Neoadjuvant Therapy 2 Monatide (IMS 3015) 2 Metformin 2 Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02233374 2022-10-28

PRISM

Royal North Shore Hospital

Phase NA Completed

Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡